Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...
BWET jumps 27.5% in the past month even as the S&P 500 declines, with UNG also rising and FCG offering a different ex...
The White House rejected Elon Musk’s public offer to fund TSA salaries during the budget stalemate, setting off a fre...
With markets volatile in May 2026, delaying Social Security to age 70 can raise lifetime benefits. The breakeven poin...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
A surge in quantum-tech optimism helped lift IonQ shares even without direct news from the company. Here’s what happe...
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
Investors target a $720,000 annual income from a diversified portfolio that mimics a light consulting practice, weigh...
A 2x leveraged ETF tracking Nvidia fell 12% in a single session while Nvidia itself declined 6.2%, erasing roughly $2...
The Small Business Administration has paused new loans for green card holders, a policy shift that could disrupt immi...
A high-profile moment can ripple into personal finances. This piece examines the Tyson Paris Fury Face backlash, what...